Fosun Pharma USA Inc. 3

3 · NATURES SUNSHINE PRODUCTS INC · Filed Jun 9, 2025

Insider Transaction Report

Form 3
Period: 2025-06-05
Holdings
  • Common Stock

    2,854,607
Footnotes (1)
  • [F1]. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. transferred these shares to its wholly-owned subsidiary, Fosun Pharma USA Inc. Following the transfer, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Fosun Pharma USA Inc. intend to jointly file Section 16 reports with respect to these shares.

Documents

1 file
  • 3
    form3.xmlPrimary

    FORM 3